SWISS_CLEARANCE - Compartment Compressibility Monitoring Using CPM#1
Primary Purpose
Compartment Syndromes
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Measurement of compartment compressibility
Sponsored by

About this trial
This is an interventional diagnostic trial for Compartment Syndromes
Eligibility Criteria
Inclusion Criteria:
- Healthy volunteer
- Male or female
- Age 18 to 84 years
Exclusion Criteria:
- Previous surgery to or fracture of the leg and/or forearm
- Peripheral arterial or venous disease
- History of compartment syndrome
- Limb anomalies
- General muscle disorder
Sites / Locations
- Universitäres Notfallzentrum, Inselspital Bern
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
CPM#1
Arm Description
Compartment compressibility ratio measurement using the CPM#1 device
Outcomes
Primary Outcome Measures
Inter-operator reproducibility with 3 raters
Inter-operator reproducibility will be assessed using intra-class correlation coefficients (two-way random effects, single rater, absolute agreement). Three independent raters will conduct 4 measurements per compartment site on 14 relaxed forearms (7 volunteers, 1 site per forearm), and 14 relaxed legs (7 volunteers, 2 sites per leg).
Secondary Outcome Measures
Intra-operator reproducibility
Intra-operator reproducibility will be assessed using intra-class correlation coefficients (two-way mixed effects, single measurement, absolute agreement). Three independent raters will conduct 4 measurements per compartment site on 14 relaxed forearms (7 volunteers, 1 site per forearm), and 14 relaxed legs (7 volunteers, 2 sites per leg).
Validation of number of measurement repetitions
Clinically needed number of measurements for optimized repeatability will be assessed on 2, 3 and 4 measurement repetitions per compartment site based on 14 relaxed forearms (7 volunteers, 1 site per forearm), and 14 relaxed legs (7 volunteers, 2 sites per leg).
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05483946
Brief Title
SWISS_CLEARANCE - Compartment Compressibility Monitoring Using CPM#1
Official Title
Validation of CPM#1 Compressibility Ratio in a Clinical Study of Healthy Volunteers: Evaluation of the Test-retest Repeatability
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
November 1, 2022 (Actual)
Primary Completion Date
November 1, 2022 (Actual)
Study Completion Date
November 1, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Compremium AG
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Compartment syndrome is a very serious musculoskeletal disorder, which can lead to potentially devastating consequences, such as limb amputation and life- threatening conditions. It is a well described medical condition considered to be an orthopaedic emergency affecting all ages.
Even though compartment syndrome is a well described medical condition, the appropriate treatment (i.e., fasciotomy to release tissue pressure) is invasive and involves its own risks. Furthermore, and of most critical importance is the timing for the intervention of a fasciotomy. The concerned limb may already have had severe, sometimes even irreversible, tissue damage due to high intra- compartmental pressure within 6 to 10 hours.
The standard diagnostic method for compartment syndrome is an invasive intra-compartmental pressure measurement via insertion of a pressure monitoring device into the muscle compartment. Commercially available intra compartmental pressure monitors have a highly variable intra-observer reproducibility and user errors are common.
Compared to the invasive modalities, the Compremium Compartmental Compressibility Monitoring System (CPM#1) shows promising advantages for the clinical application. Not only is the technology used for the CPM#1 device safe and non-invasive for the patient with only initial training required for the healthcare professionals, but it has also demonstrated high intra- and inter- observer reproducibility (as per bench tests and clinical settings with prototypes, to be confirmed in clinical studies like this one). The use of the CPM#1 device therefore facilitates the measurements, as it is based on pre-existing ultrasound methods and avoids any further risks to the patients compared to invasive compartmental pressure diagnosis methods.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Compartment Syndromes
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
Investigators will be blinded to the measurement results
Allocation
N/A
Enrollment
7 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CPM#1
Arm Type
Experimental
Arm Description
Compartment compressibility ratio measurement using the CPM#1 device
Intervention Type
Device
Intervention Name(s)
Measurement of compartment compressibility
Intervention Description
Application of the CPM#1 device for compartment compressibility ratio measurement - for each participant, a pre-defined number of measurements will be conducted per leg and forearm
Primary Outcome Measure Information:
Title
Inter-operator reproducibility with 3 raters
Description
Inter-operator reproducibility will be assessed using intra-class correlation coefficients (two-way random effects, single rater, absolute agreement). Three independent raters will conduct 4 measurements per compartment site on 14 relaxed forearms (7 volunteers, 1 site per forearm), and 14 relaxed legs (7 volunteers, 2 sites per leg).
Time Frame
During the procedure which should last about 3 hours/patient
Secondary Outcome Measure Information:
Title
Intra-operator reproducibility
Description
Intra-operator reproducibility will be assessed using intra-class correlation coefficients (two-way mixed effects, single measurement, absolute agreement). Three independent raters will conduct 4 measurements per compartment site on 14 relaxed forearms (7 volunteers, 1 site per forearm), and 14 relaxed legs (7 volunteers, 2 sites per leg).
Time Frame
During the procedure which should last about 3 hours/patient
Title
Validation of number of measurement repetitions
Description
Clinically needed number of measurements for optimized repeatability will be assessed on 2, 3 and 4 measurement repetitions per compartment site based on 14 relaxed forearms (7 volunteers, 1 site per forearm), and 14 relaxed legs (7 volunteers, 2 sites per leg).
Time Frame
During the procedure which should last about 3 hours/patient
Other Pre-specified Outcome Measures:
Title
Assessment of adverse events and serious adverse events
Description
Safety of the procedure will be assessed by documenting adverse events and serious adverse events (description of the adverse events, number of participants).
Time Frame
During the procedure which should last about 3 hours/patient
Title
Assessment of device deficiencies
Description
Safety of the procedure will be assessed by documenting device deficiencies (description)
Time Frame
During the procedure which should last about 3 hours/patient
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
84 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy volunteer
Male or female
Age 18 to 84 years
Exclusion Criteria:
Previous surgery to or fracture of the leg and/or forearm
Peripheral arterial or venous disease
History of compartment syndrome
Limb anomalies
General muscle disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Beat Lehmann
Organizational Affiliation
Universitäres Notfallzentrum, Inselspital Bern
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitäres Notfallzentrum, Inselspital Bern
City
Bern
ZIP/Postal Code
3010
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
SWISS_CLEARANCE - Compartment Compressibility Monitoring Using CPM#1
We'll reach out to this number within 24 hrs